745 related articles for article (PubMed ID: 29655689)
1. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.
Qu L; Zou W; Wang Y; Wang M
Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689
[TBL] [Abstract][Full Text] [Related]
2. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products.
Qu L; Li X; Xiong Y; Wang Z; Zhou Y; Zou W; Tang J; Wang M
Pharmacol Res; 2022 Dec; 186():106528. PubMed ID: 36332812
[TBL] [Abstract][Full Text] [Related]
4. Monographs, list entries, public statements.
Chinou I
J Ethnopharmacol; 2014 Dec; 158 Pt B():458-62. PubMed ID: 25193681
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of difficult problems on European Union laws and regulations of traditional herbal medicinal products].
Qu LP; Zhang XQ; Xiong Y; Wang YT; Zou WJ
Zhongguo Zhong Yao Za Zhi; 2017 Oct; 42(20):4040-4044. PubMed ID: 29243444
[TBL] [Abstract][Full Text] [Related]
6. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
Vlietinck A; Pieters L; Apers S
Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
[TBL] [Abstract][Full Text] [Related]
7. Market access for Chinese herbal medicinal products in Europe-A ten-year review of relevant products, policies, and challenges.
Xiong Y; Li M; Sun P; Liang W; Hornbeck RG; Che X; Rao C; Zhao Y; Guo L; Huang Y; Yang H; Li P; Kroes BH; Cui X; Franz G; Wang M
Phytomedicine; 2022 Aug; 103():154237. PubMed ID: 35688101
[TBL] [Abstract][Full Text] [Related]
8. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
9. [The regulatory framework for complementary and alternative medicines in Europe].
Knöss W; Stolte F; Reh K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
[TBL] [Abstract][Full Text] [Related]
10. Assessment of genotoxicity of herbal medicinal products: a co-ordinated approach.
Kelber O; Steinhoff B; Kraft K;
Phytomedicine; 2012 Mar; 19(5):472-6. PubMed ID: 22301069
[TBL] [Abstract][Full Text] [Related]
11. Regulation of medicinal plants for public health--European community monographs on herbal substances.
Knöss W; Chinou I
Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
[TBL] [Abstract][Full Text] [Related]
12. The use of community herbal monographs to facilitate registrations and authorisations of herbal medicinal products in the European Union 2004-2012.
Peschel W
J Ethnopharmacol; 2014 Dec; 158 Pt B():471-86. PubMed ID: 25043780
[TBL] [Abstract][Full Text] [Related]
13. Could EU herbal monographs contribute to Malta's treatment armamentarium?
Micallef B; Attard E; Serracino-Inglott A; Borg JJ
Phytomedicine; 2015 Mar; 22(3):400-5. PubMed ID: 25837278
[TBL] [Abstract][Full Text] [Related]
14. The new European legislation on traditional herbal medicines: main features and perspectives.
Silano M; De Vincenzi M; De Vincenzi A; Silano V
Fitoterapia; 2004 Mar; 75(2):107-16. PubMed ID: 15030913
[TBL] [Abstract][Full Text] [Related]
15. Regulations applicable to plant food supplements and related products in the European Union.
Silano V; Coppens P; Larrañaga-Guetaria A; Minghetti P; Roth-Ehrang R
Food Funct; 2011 Dec; 2(12):710-9. PubMed ID: 21997496
[TBL] [Abstract][Full Text] [Related]
16. Medicinal plants and their preparations in the European market: Why has the harmonization failed? The cases of St. John's wort, valerian, ginkgo, ginseng, and green tea.
Bilia AR; Costa MDC
Phytomedicine; 2021 Jan; 81():153421. PubMed ID: 33291029
[TBL] [Abstract][Full Text] [Related]
17. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
18. Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJ.
Borg JJ; Laslop A; Pani L; Maciulaitis R; Melchiorri D
Sci Pharm; 2014; 82(3):541-54. PubMed ID: 25853067
[TBL] [Abstract][Full Text] [Related]
19. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe.
van Galen E
J Ethnopharmacol; 2014 Dec; 158 Pt B():498-502. PubMed ID: 25043781
[TBL] [Abstract][Full Text] [Related]
20. TradReg 2013: regulation of herbal and traditional medicinal products--European and global strategies--international symposium.
Cranz H; Anquez-Traxler C
J Ethnopharmacol; 2014 Dec; 158 Pt B():495-7. PubMed ID: 25281419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
